ACE Inhibition in Diabetic Patients Roger A. RodbyEdmund J. Lewis Current Opinion 15 November 2012 Pages: 315 - 320
Methadone Programmes George E. RalstonPhilip Wilson Leading Article 15 November 2012 Pages: 321 - 326
Health-Related Quality of Life in Inflammatory Bowel Disease Glenn M. EisenRichard G. Farmer Leading Article 15 November 2012 Pages: 327 - 335
A Review of the Progress Towards Developing Health-Related Quality-of-Life Instruments for International Clinical Studies and Outcomes Research Roger T. AndersonNeil K. AaronsonWendy L. McBee Review Article 15 November 2012 Pages: 336 - 355
Pharmacoeconomics of Chronic Nonmalignant Pain Martin J. ZagariPeter D. MazonsonWilliam C. Longton Review Article 15 November 2012 Pages: 356 - 377
Characterisation of Asthma Management in the Fallon Community Health Plan from 1988 to 1991 Stephan F. LanesBrenda M. BirmannNancy A. Dreyer Original Research Article 15 November 2012 Pages: 378 - 385
The Economics of a Pharmacy-Based Central Intravenous Additive Service for Paediatric Patients David J. ArmourChris J. CairnsGraham Davies Original Research Article 15 November 2012 Pages: 386 - 394
Full-Cost Determination of Different Levels of Care in the Intensive Care Unit John J. DoyleJulian P. CascianoJohn E. Paul Original Research Article 15 November 2012 Pages: 395 - 406
Sertraline Rick DavisMichelle I. Wilde Pharmacoeconomic Drug Evaluation 15 November 2012 Pages: 409 - 431
Use of Confidence Intervals in Health Economic Studies José A. Sacristán Correspondence 15 November 2012 Pages: 432 - 433
Economics of Serotonin 5-HT3 Antagonists Jacques BonneterreCaroline Bercez Correspondence 15 November 2012 Pages: 433 - 434